NEWS

Year 2010

	New PDUFA goal date for ezogabine in the U.S.2010-08-31 08:20 - Pressrelease - pdf
	Meda acquires Alaven, a US specialty pharma company2010-08-30 13:39 - Pressrelease - pdf
	Ezogabine receives positive vote from FDA advisory committee2010-08-12 08:35 - Pressrelease - pdf
	Meda AB (publ) – Interim report, January–June 20102010-08-04 08:00 - Interim report - pdf
	Meda receives one-time payment of 45 MEUR2010-07-23 08:00 - Pressrelease - pdf
	Meda acquires exclusive rights to new treatment of actinic keratosis2010-05-12 11:30 - Pressrelease - pdf
	Onsolis approved in Canada2010-05-10 13:58 - Pressrelease - pdf
	Meda acquires exclusive rights to flupirtine for fibromyalgia, a potential USD billion indication2010-05-07 09:45 - Pressrelease - pdf
	Meda AB (publ) AGM bulletin2010-05-05 19:38 - Minutes of annual general meeting - pdf
	Meda AB (publ) – Interim report, January-March 20102010-05-05 08:00 - Quarterly report - pdf
	Meda AB (publ): Notification to shareholders of the annual general meeting2010-04-01 08:50 - Notice to convene annual general meeting - pdf
	Nomination committee proposes re-election of all board members2010-02-24 16:30 - Pressrelease - pdf
	Meda AB (publ) – 2009 year-end report2010-02-16 08:00 - Annual Financial Statement - pdf
	Meda in-licenses exclusive rights to Xerese™2010-02-15 15:00 - Pressrelease - pdf
	Meda in-licenses exclusive rights to Ceplene2010-01-11 08:00 - Pressrelease - pdf